Mohammed Bin Rashid University of Medicine and Health Sciences, in cooperation with the Dubai Health Authority and Brithonex, is currently conducting a joint clinical trial on 2,500 clients of the Nad Al Hammar Health Center of the Dubai Health Authority to assess the accuracy of the rapid breathing test to detect Covid-19 disease within one minute. .
Brithonix – a startup affiliated with the National University of Singapore – had conducted a pilot study in the Republic of Singapore that included 180 people and achieved results ranging from 93% to 95% through the use of machine learning algorithms.
The Director of the Department of Laboratories and Genetics at the Dubai Health Authority, Dr. Hussein Al-Samt, emphasized the great interest that the authority attached to, in line with the vision of the wise leadership, to promote and develop scientific research and innovation. Covid-19 disease, pointing out the importance of this technology, which may contribute significantly to the rapid diagnosis of patients in a period not exceeding 60 seconds for each patient, explaining that this type of rapid diagnosis may contribute significantly to strengthening efforts to confront the Covid-19 pandemic.
On her part, Director of the Nad Al Hamar Primary Health Care Center at the Dubai Health Authority, Dr. Nada Al-Mulla, indicated the importance of this study and its effective role in reducing laboratory procedures and reducing the time it takes to obtain results compared to the laboratory examination PCR, which will speed up the conduct of laboratory tests.
The principal investigator of the study, the leader of the examination track team at the Control and Control Center to Combat Coronavirus, and Assistant Professor of Family Medicine at the Mohammed Bin Rashid University of Medicine and Health Sciences Dr. Hanan Al-Suwaidi emphasized the pioneering role that the university plays in the field of medical research and innovation in the region. Conducting many researches in general and Covid-19 disease in particular, in cooperation with national and international institutions, referring to the recent study conducted by the university on the accuracy of the saliva test to detect Covid-19 in children, and after the research, this technique was applied in health authority centers In Dubai. Where the world was witness to medical research, innovation and technology and its assistance in dealing with Covid-19, indicating the university’s keenness to increase and enhance research in the field of technology because of its ability to radically improve health care and provide accurate care and laboratory results to patients.
This laboratory examination is characterized by ease, as all a person needs is to blow into a single-use piece, which is connected to a high-precision breathing sampling system, where the breath is collected by exhaling into the device to analyze the volatile organic compound and generate a result in less than a minute.
The Mohammed Bin Rashid University of Medicine and Health Sciences and the Dubai Health Authority expressed their appreciation to the Emirates Airlines Group for providing all support to the transfer of the breath test system from Singapore to Dubai, extending thanks and appreciation to His Excellency Lu Pet Chen, Consul General of the Republic of Singapore in Dubai and the Northern Territories for his support for this study.
On his part, founder and CEO of Prithonics, Dr. Jia Chunan, explained that the initial clinical trials that the company carried out in cooperation with the National Center for Infectious Diseases in Singapore achieved accurate results with a sensitivity of 93% and an accuracy of 95%, noting that this experiment aims to verify the accuracy Results of the technology used.
The developed breath analysis technology provides quick and immediate solutions to diagnosing Covid-19, as it works by detecting the volatile organic compounds present in the breath upon exhalation. VOCs are constantly produced by different biochemical reactions in human cells, and different diseases cause certain changes in the respiratory compounds leading to changes that can be detected through a person’s breathing.
The co-founder and chief operating officer of Brithonix Du Fan said: The breath test does not cause any discomfort to the patient, as it only requires him to breathe naturally into the device, and it is also easy and people can be trained on how to perform it easily before transporting it to the detection sites.
The founding partner and head of business development at Brithonix Wayne Wei expressed his pride in this partnership between the company and each of the Mohammed Bin Rashid University of Medicine and Health Sciences and the Dubai Health Authority, to conduct this clinical trial of a breath test for the rapid detection of Covid-19 disease, expressing the gratitude of Brithonix to the group Emirates Airlines for its world-class service, sponsorship, and speed to move the breath test system to support clinical trials in Dubai.
For his part, Emirates Airlines Chief Operating Officer Adel Al-Reda said that having a quick solution to detect Covid-19 disease will greatly contribute to the reopening of international travel and other economic activities, expressing the interest that the Emirates Airlines Group attaches and its happiness in contributing to the transfer of equipment for this study. The mission that will support Dubai’s research efforts through innovative and effective methods of managing the epidemic and dealing with the pandemic.
“Since the start of the pandemic, group testing has been widely adopted as key public health strategies for disease detection and prevention, and we at the National University of Singapore are proud of our emerging technology company Prithonics for moving forward at this time and for its flexibility to transform disease,” said National University of Singapore Vice President for Organizational Innovation, Prof. Dr. Freddy Boyer. Cancer detection technology into a technique that can be used to detect Covid-19 disease, expressing his confidence in this technology, which will constitute a source of strength for countries moving towards gradually reopening the economy.
#Mohammed #Bin #Rashid #University #Dubai #Health #Brithonix #conducting #clinical #trials #rapid #breathing #test #detect #COVID19